Spotlight Falls On HIV Prevention Drugs, With Some Criticism Of Makers

Stat reports on criticisms that ViiV’s generic HIV-preventing drug will not be available for up to four years. Cheap local copies of GSK’s anti-HIV drug could be available sooner. ADHD drugs and Rite Aid, a data breach at OneTouchPoint, soaring profits at Pfizer, and more…

Source: khn.orgRead more